Novavax | Capitale Ordinario





Capitale Ordinario Cambiamento Data
Adma Biologics USD 236.62M 242K 2024-12
Agenus USD 266K 30K 2025-03
AstraZeneca USD 1.55B 1.16B 2025-09
BioCryst Pharmaceuticals USD 1.9M 3K 2023-09
Cassava Sciences USD 48.31M 48.26M 2025-09
Dynavax Technologies USD 117.23M 117.11M 2025-06
Geron USD 638.02M 637.38M 2025-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
MannKind USD 307.03M 303.99M 2025-09
Merck USD 2.49B 15.79M 2025-09
Minerva Neurosciences USD 1000 0 2024-09
Moderna USD 391M 2M 2025-09
Novartis USD 1.92B 17.06M 2025-09
Novavax USD 1.62M 211K 2024-09
Pfizer USD 5.69B 1000K 2025-09
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
TG Therapeutics USD 155.21M 2.81M 2025-09


Novavax Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.